Clinical Trials Browser

Phase 2 × Has results × VGX-3100 × Clear all

NCT03180684 2023-08-25

Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)

Phase 2 Completed

33 enrolled 19 charts

Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)

NCT03499795 2023-07-14

VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2

Phase 2 Completed

23 enrolled 19 charts

GastrointestinalGynecologic

Squamous Intraepithelial Lesions, Anus Neoplasms